Found 12 matching trials
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis PHASE4 This is a prospective, multicenter, open-label, blinded-endpoint, randomize...
Show More Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS) N/A The purpose of this clinical trial is to evaluate the impact of early initi...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia PHASE4 The aim is to evaluate the safety and efficacy of vunakizumab combined with...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2ร2 Randomized Controlled Trial PHASE4 This study aims to evaluate whether digital cognitive training and/or inten...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC PHASE2 The study aims to evaluate the efficacy and safety of Recaticimab and Adebr...
Show More Location
Multiple Locations
Learn More & Join Trial
Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period PHASE4 This project team is conducting a multicenter randomized controlled study, ...
Show More Location
Multiple Locations
Learn More & Join Trial
PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis PHASE3 An investigator-initiated, prospective, multicenter, randomized, double-bli...
Show More Location
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Learn More & Join Trial
PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke PHASE4 This study is a prospective, multicenter, double-blind, randomized, placebo...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Adebrelimab or Retlirafusp Alfa Plus Recaticimab and Chemotherapy for Resectable NSCLC PHASE2 Although phase III studies have confirmed the efficacy and safety of periop...
Show More Location
Multiple Locations
Learn More & Join Trial
Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion PHASE3 A prospective, multicenter, open-label, randomized controlled study to asse...
Show More Location
Shanghai East Hospital, Tongji University
Learn More & Join Trial